» Articles » PMID: 38504369

Development of the China's List of Ambulatory Care Sensitive Conditions (ACSCs): a Study Protocol

Overview
Publisher Biomed Central
Specialty Public Health
Date 2024 Mar 20
PMID 38504369
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The hospitalization rate of ambulatory care sensitive conditions (ACSCs) has been recognized as an essential indicator reflective of the overall performance of healthcare system. At present, ACSCs has been widely used in practice and research to evaluate health service quality and efficiency worldwide. The definition of ACSCs varies across countries due to different challenges posed on healthcare systems. However, China does not have its own list of ACSCs. The study aims to develop a list to meet health system monitoring, reporting and evaluation needs in China.

Methods: To develop the list, we will combine the best methodological evidence available with real-world evidence, adopt a systematic and rigorous process and absorb multidisciplinary expertise. Specific steps include: (1) establishment of working groups; (2) generations of the initial list (review of already published lists, semi-structured interviews, calculations of hospitalization rate); (3) optimization of the list (evidence evaluation, Delphi consensus survey); and (4) approval of a final version of China's ACSCs list. Within each step of the process, we will calculate frequencies and proportions, use descriptive analysis to summarize and draw conclusions, discuss the results, draft a report, and refine the list.

Discussion: Once completed, China's list of ACSCs can be used to comprehensively evaluate the current situation and performance of health services, identify flaws and deficiencies embedded in the healthcare system to provide evidence-based implications to inform decision-makings towards the optimization of China's healthcare system. The experiences might be broadly applicable and serve the purpose of being a prime example for nations with similar conditions.

Citing Articles

The Impact of Hospital Competition on the Quality of Care in Europe: A Systematic Review.

Timofeyev Y, Goldenova V, Mantaeva E, Jakovljevic M Healthcare (Basel). 2024; 12(22).

PMID: 39595417 PMC: 11593865. DOI: 10.3390/healthcare12222218.


A review on the evolving environment of medical device real-world evidence regulation on market access in the USA.

Shi L, Xuan D, Jakovljevic M Cost Eff Resour Alloc. 2024; 22(1):75.

PMID: 39456032 PMC: 11515808. DOI: 10.1186/s12962-024-00582-9.


Impact of Insurance on Readmission Rates, Healthcare Expenditures, and Length of Hospital Stay among Patients with Chronic Ambulatory Care Sensitive Conditions in China.

Xu Zheng E, Zhu X, Zhu Y, Qin Z, Zhang J, Huang Y Healthcare (Basel). 2024; 12(17).

PMID: 39273822 PMC: 11395110. DOI: 10.3390/healthcare12171798.

References
1.
Qaseem A, Snow V, Owens D, Shekelle P . The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010; 153(3):194-9. DOI: 10.7326/0003-4819-153-3-201008030-00010. View

2.
Sundmacher L, Fischbach D, Schuettig W, Naumann C, Augustin U, Faisst C . Which hospitalisations are ambulatory care-sensitive, to what degree, and how could the rates be reduced? Results of a group consensus study in Germany. Health Policy. 2015; 119(11):1415-23. DOI: 10.1016/j.healthpol.2015.08.007. View

3.
Ansari Z, Laditka J, Laditka S . Access to health care and hospitalization for ambulatory care sensitive conditions. Med Care Res Rev. 2006; 63(6):719-41. DOI: 10.1177/1077558706293637. View

4.
Tsevat J, Moriates C . Value-Based Health Care Meets Cost-Effectiveness Analysis. Ann Intern Med. 2018; 169(5):329-332. DOI: 10.7326/M18-0342. View

5.
Purdy S, Griffin T, Salisbury C, Sharp D . Ambulatory care sensitive conditions: terminology and disease coding need to be more specific to aid policy makers and clinicians. Public Health. 2009; 123(2):169-73. DOI: 10.1016/j.puhe.2008.11.001. View